NIH-funded research R01 grant

Investigating how lymphatic vessels in the brain affect immune communication in young children.

Official title: Role of meningeal lymphatic vasculature in neuroimmune communication development

Funded at Yale University · NIH-11112292 · Data updated 2026-11-12

This study is looking at how tiny vessels in the brain help the immune system talk to the brain during early life, especially in young mice, to learn more about how this communication might affect kids with brain tumors like medulloblastoma.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startFebruary 15, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$494,067
NIH project number5R01NS130057-03
Project IDNIH-11112292 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include young children, particularly those diagnosed with brain tumors or other neuroimmune conditions.

Less likely to help

Patients who are adults or do not have conditions related to neuroimmune communication may not benefit from this research.

What this research studies

This research explores the role of developing meningeal lymphatic vessels (MLVs) in the communication between the immune system and the brain during early postnatal life. By studying young mice, the researchers aim to understand how these vessels influence immune responses, particularly in the context of pediatric brain tumors like medulloblastoma. The study employs advanced imaging techniques and molecular analysis to uncover the mechanisms of neuroimmune communication and the potential for enhancing immune responses through specific signaling pathways.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for improving immune responses in children with brain tumors.

How similar studies have gone: While the specific focus on MLVs in pediatric neuroimmune communication is novel, related research has shown promise in understanding immune responses in other contexts.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Thomas, Jean-Leon — Yale University
  • Study coordinator: Thomas, Jean-Leon

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.